炎症在神经精神障碍中的现状与未来方向
本文为叙述性综述,总结临床人群、新试验与临床前模型的新证据。证据趋同提示炎症在精神病、抑郁与孤独症的部分患者亚组中起重要作用。IL-6、T细胞调控、免疫代谢功能与补体系统是进一步研究的基础领域,新治疗尚未产生临床影响,但靶向试验正在进行。
要点
- 炎症可能仅涉及精神病、抑郁与孤独症的部分患者亚组。
- IL-6、T细胞调控、免疫代谢与补体系统是重点研究方向。
- 新治疗尚未达到临床影响,靶向试验仍在进行中。
核心结论
- 炎症相关免疫病理过程可能对许多重性精神疾病起关键作用,但作用范围与转化为治疗的时间仍待明确。
- 炎症在精神病、抑郁与孤独症的部分患者亚组中起重要作用,证据趋同。
研究设计与样本
- 叙述性综述,总结来自临床人群、新试验与临床前模型的新证据。
主要发现
- IL-6、T细胞调控、免疫代谢功能与补体系统是进一步研究的基础领域。
- 新治疗尚未达到临床影响,但靶向试验正在进行中。
- 开发与完善人类细胞模型有助于机制靶点验证及理解因果通路与网络。
临床怎么用
- 推进至临床影响需要跨学科、跨转化尺度的协作统一努力。
- 需聚焦验证证据与新旧治疗潜力最强的关键新兴靶点。
局限性
- 为叙述性综述,未报告系统检索策略与定量合并结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: There has been a large increase in research focusing on inflammation across psychiatric disorders, with the hope of achieving breakthroughs seen with this approach in cancer and other conditions. Current findings suggest that immune-related pathophysiological processes involving inflammation could play a key role for many major mental illnesses. How far reaching this role would be and how soon we can expect translation into treatment, however, remain open questions. OBSERVATIONS: In this narrative review, new evidence from clinical populations, new trials, and preclinical models was summarized. Converging evidence suggests that inflammation plays a significant role in subgroups of patients with psychosis, depression, and autism. Interleukin (IL) 6, T-cell control, immune-metabolic function, and the complement system represent fundamental areas of further research. New treatments have yet to reach clinical impact, but targeted trials are ongoing. Developing and refining human cellular models will aid mechanistic target validation and further understanding of causal pathways and networks. CONCLUSIONS AND RELEVANCE: To advance to and achieve clinical impact, investigations need to include a collaborative, united effort, pulling information across disciplines and translational scales. A focused approach is needed to validate key emerging targets, where evidence and potential for new and repurposed treatments are strongest.
引用
- Upthegrove R, Corsi-Zuelli F, Couch ACM, et al. Current Position and Future Direction of Inflammation in Neuropsychiatric Disorders: A Review. JAMA Psychiatry. 2025. PMID: 40632530. doi:10.1001/jamapsychiatry.2025.1369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。